Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

25.86

+0.94 (3.77%)

Aug 19, 2026, 4:00 PM EDT - Market closed

Bicara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	96.6	96.69	489.71	230.44	4.16
Short-Term Investments	400.66	318.12	-	-	-
Cash & Short-Term Investments	497.26	414.8	489.71	230.44	4.16
Cash Growth	13.89%	-15.30%	112.51%	5442.09%	-
Receivables	-	-	-	0.1	0.07
Prepaid Expenses	6.56	7.25	12.82	0.53	0.76
Total Current Assets	503.82	422.05	502.53	231.07	4.98
Property, Plant & Equipment	1.51	2.03	0.85	0.82	0.64
Other Long-Term Assets	6.91	6.91	6.62	1.99	0.94
Total Assets	512.24	430.99	510	233.98	6.7

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	8.46	5.52	3.89	3.19	5.14
Accrued Expenses	33.85	22.32	13.49	11.61	18.76
Current Portion of Leases	1.16	1.12	0.61	0.29	-
Total Current Liabilities	43.48	28.95	17.99	15.09	23.9
Long-Term Leases	-	0.59	0.13	0.37	-
Other Long-Term Liabilities	-	-	-	0.02	0.09
Total Liabilities	43.48	29.54	18.12	15.47	23.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	939.94	760.17	712.88	4.25	2.23
Retained Earnings	-470.61	-358.97	-221.02	-153.02	-101.04
Comprehensive Income & Other	-0.57	0.24	-	-	-
Total Common Equity	468.77	401.45	491.88	-148.77	-98.8
Shareholders' Equity	468.77	401.45	491.88	218.51	-17.28
Total Liabilities & Equity	512.24	430.99	510	233.98	6.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	1.16	1.71	0.74	0.66	-
Net Cash (Debt)	496.1	413.09	488.97	229.78	4.16
Net Cash Growth	14.21%	-15.52%	112.80%	5426.29%	-
Net Cash Per Share	8.32	7.56	29.10	396.10	9.69
Filing Date Shares Outstanding	66.17	65.47	54.52	34.26	0.43
Total Common Shares Outstanding	65.93	54.44	54.44	0.64	0.43
Working Capital	460.35	393.1	484.54	215.99	-18.91
Book Value Per Share	7.11	7.37	9.04	-232.15	-230.26
Tangible Book Value	468.77	401.45	491.88	-148.77	-98.8
Tangible Book Value Per Share	7.11	7.37	9.04	-232.15	-230.26

SEC Filings: 10-K · 10-Q